Phoenix House’s New Medical Director Has Significant Public Health Background

Circle Connections: New Talent The new chief medical officer of Phoenix House, one of the nation's largest nonprofit addiction treatment organizations, has a lengthy public health background that included work to encourage buprenorphine treatment and naloxone use in overdose prevention in New York state. Andrew Kolodny, MD, officially began his new role at Phoenix House earlier this month; just prior to making that transition he had served as chair of psychiatry at Maimonides Medical Center in New York City. Advances that occurred at the hospital during his time there included development of a psychiatric emergency room and a co . . .